Results

Total Results: 2,337 records

Showing results for "response".

1681. Comparative Effectiveness Review (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
      January 01, 2006 - osteoarthritis; FOBT - fecal occult blood test; PGA - patient global assessment;PGART Patient Global Response … 1.00- 1.64)Fenoprofen: OR 1.95 (1.16, 3.30)Ibuprofen: OR 1.02 (0.88, 1.18) No dose- or duration- response … Clinical response rate The 2 placebo controlled trials showed paracetamol better than placebo, but results … Clinical response RRs were 16 (95% CI 2.32-110.45; p=0.02) and 1.67 (95% CI 1.00-2.76; p=0.05). … Pooled response RR 1.24 (95% CI 1.08-1.41, p=0.001).

1682. Microsoft Word - Comp Eff 10.doc (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
      January 01, 2007 - Patients on a diuretic dosage should be adjusted according to BP response, and the diuretic should … Recommended dosage for elderly patients is 10 mg once daily followed by titration to the optimal response … Dosage adjustment according to BP response. … Based on BP response, hydrochlorothiazide 12.5 mg daily should be added and/or dose of losartan should … BP response is dose-related over range of 20-80 mg.

1683. Glaucoma-Treatment-Appendices-11-5-10-2 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
      October 27, 2009 - • foreign body sensation • dryness • itching • hypotony • blurred or dimmed vision • allergic response

1684. Icd-Categories-Prevalence-Reimbursement Research (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/icd-categories-prevalence-reimbursement_research.pdf
      January 01, 2011 - Prevalence and Medicare reimbursement by recurrent International Classification of Diseases categories, 2006-2009 Utilization and Costs Data Points #5 In 2009, Medicare reimbursement for inpatient claims totaled $126.7 billion, more than 25 percent of which was for circula- tory diseases. The total per claim r…

1685. Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stakeholder-engagement_research.pdf
      September 01, 2011 - Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program Research White Paper Stakeholder Involvement in Improving Comparative Effectiveness Reviews: AHRQ and the Effective Health Care Program Res…

1686. Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
      June 01, 2020 - Evidence-based Practice Center Technical Brief Protocol: Disparities and Barriers for Pediatric Cancer Survivorship Care Evidence-based Practice Center Technical Brief Protocol Project Title: Disparities and Barriers for Pediatric Cancer Survivorship Care I. Background and Objectives for the Technica…

1687. Arthritis and Nontraumatic Joint Disease (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1506.pdf
      June 01, 2015 - to two or more NSAIDs or patients who have had an inadequate response to TNF inhibitors … Patients who had never received treatment with TNF inhibitors had ASAS20 response rates of 60.0%, 66.3% … Patients given secukinumab 150 mg had significantly higher ASAS20 response rates than patients given … to two or more NSAIDs or patients who have had an inadequate response to TNF inhibitors. … Patients receiving secukinumab 75, 150, or 300 mg SC had significantly higher ACR20 response rates

1688. Procalcitonin-Guided Antibiotic Therapy | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/procalcitonin/research
      October 05, 2012 - Safer IV: Final Report on Prioritization of Patient Safety Practices for a New Rapid Review or Rapid Response … Rapid Evidence Product Oct 28, 2022 Antibody Response Following SARS-CoV-2 Infection

1689. Second-Generation Antidepressants in the Pharmacologic Treatment of Adult Depression: An Update of the 2007 Comparative Effectiveness Review | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/antidepressants-update/research
      December 05, 2011 - data were sufficient, we conducted meta-analyses of head-to-head trials of the relative benefit of response … Statistically significant differences in response rates between some drugs are small and likely not clinically

1690. Interventions To Improve Patient Adherence to Hepatitis C Treatment: Comparative Effectiveness | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/hepatitis-c-treatment-adherence/research
      December 20, 2012 - In the eight studies reporting sustained viral response (SVR), two showed a statistically significantly … Conclusions Adherence interventions might improve patient adherence and viral response in patients

1691. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/plasma-cell-dyscrasias-sflc-assay-future/research
      September 19, 2012 - cells in the bone marrow and produce immunoglobulins that constitute the body's normal humoral immune response … The assay could allow for quantitative monitoring of response and remission after treatment and provide

1692. Management of Insomnia Disorder | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/insomnia/research
      December 30, 2015 - Outcome reporting and intervention effect sizes varied, and a large placebo response was often observed … Effect sizes vary, and a large placebo response is sometimes observed.

1693. The purpose of our tool is to compile a comprehensive list of questions that may be used to evaluate the quality of non-randomized studies of interventions or exposures (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/reliability-testing-grading-evidence_research.pdf
      May 01, 2012 - Exercise considered straightforward by study team RA Benefits: ACR20 response 5 studies 19 … The project team created electronic response forms to collect information from reviewers through … in agreement with the most popular response among all reviewers; otherwise it was coded as 0. … We tested whether the likelihood of a reviewer‘s response agreed with the most popular response, through … 1 if the response was the most popular response and 0 otherwise) and the stratification (subgroup)

1694. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/psoriasis-chronic_research-protocol.pdf
      January 10, 2012 - The presence of activated T cells within psoriatic plaques and the response to T cell-directed therapy … to conventional therapy, including intolerance and refractory response to infliximab; reducing signs … TNF-α Treatment for reducing signs and symptoms of Crohn's disease and maintaining clinical response … in adult patients with active moderate-to-severe disease with an inadequate response to conventional … Variance imputation for overviews of clinical trials with continuous response.

1695. Fractional Exhaled Nitric Oxide Clinical Utility in Asthma Management (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/asthma-nitric-oxide_research-protocol.pdf
      September 06, 2016 - to support the diagnosis of asthma as well as monitor the disease activity (inflammation) and the response … assess which treatments are likely to be most helpful to a given patient 12, 13and/or to follow the response … In addition to have some possible advantages over other tests to select treatment and measure response … 1.d: What is the clinical utility of FeNO measurements to monitor response to treatment in individuals … NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response

1696. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/chronic-kidney-disease-anemia/research
      January 14, 2013 - (ESAs) for the anemia often develops iron deficiency, because the iron requirements for achieving a response … Nov 01, 2024 Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response

1697. Drug Therapy for Psoriatic Arthritis in Adults: Update of a 2007 Report | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/arthritis-psoriatric/research
      June 01, 2012 - No difference in treatment response was found between the combination of an anti-tumor necrosis factor … Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response

1698. Otitis Media With Effusion: Comparative Effectiveness of Treatments | Effective Health Care (EHC) Program
      effectivehealthcare-admin.ahrq.gov/products/ear-infection/research
      May 04, 2013 - Evidence Product Jul 11, 2024 Dental Care for People With Sickle Cell Disease: A Rapid Response … Rapid Evidence Product Jul 11, 2024 Dental Care for People With Hemophilia: A Rapid Response

1699. Osheroff_Respondent_Ebell 2 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/use_of_handheld_osheroff_respondent.pdf
      January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm)     Slide  1:  Ebell/Handheld  Decision  Support:  Osheroff  Response

1700. Layout 1 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
      September 01, 2011 - These categories are useful in examining potential differences in treatment response and prognosis. … 4.0 - Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM) • Composite measures of response … and intra-rater reliability, internal reliability, construct validity, responsiveness (standardized response … The current response criteria of the ACR Pediatric 30, a composite measure that includes articular … The current response criteria of the ACR 10 Pediatric 30 definition of improvement, a composite measure